SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018704
Filing Date
2024-05-10
Accepted
2024-05-10 17:21:28
Documents
56
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 764886
2 ex31-1.htm EX-31.1 15836
3 ex31-2.htm EX-31.2 15671
4 ex32-1.htm EX-32.1 7065
5 ex32-2.htm EX-32.2 7023
  Complete submission text file 0001493152-24-018704.txt   3901883

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rnxt-20240331.xsd EX-101.SCH 30118
7 XBRL CALCULATION FILE rnxt-20240331_cal.xml EX-101.CAL 33471
8 XBRL DEFINITION FILE rnxt-20240331_def.xml EX-101.DEF 120181
9 XBRL LABEL FILE rnxt-20240331_lab.xml EX-101.LAB 273639
10 XBRL PRESENTATION FILE rnxt-20240331_pre.xml EX-101.PRE 212417
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 512843
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 24936078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)